MEXC, a leading global cryptocurrency trading platform, took center stage at the first-ever Crypto Content Creator Campus ...

Financially stable C4 Therapeutics (CCCC) is worth watching for patient investors, but current lack of definitive data poses ...

The Crypto Content Creator Campus (CCCC) has highlighted the inspiring work of the Blockchain for Good Alliance (BGA), a long ...

The 2024 Crypto Content Creator Campus (CCCC), a landmark event to shape the future of the content creator economy, ...

Shares of C4 Therapeutics, Inc. (NASDAQ:CCCC – Get Free Report) have received an average rating of “Hold” from the five ...

Stifel Nicolaus analyst Bradley Canino maintained a Buy rating on C4 Therapeutics (CCCC – Research Report) today and set a price target ...

Miss chef Matin’s pastries from his now-closed Ion cafe? He’ll be serving refined pastries like $4 Sourdough Croissant and $6 ...

Dubai, UAE: The 2024 Crypto Content Creator Campus (CCCC), a landmark event shaping the future of the content creator economy, successfully wrapped up its first-ever summit in Dubai.

MEXC is proud to partner with the inaugural Crypto Content Creator Campus CCCC event, taking place this November in Dubai.

The Central Carolina Community College men’s basketball team scored an 86-84 victory at Caldwell Community College & ...

C4 Therapeutics, Inc. (CCCC) came out with a quarterly loss of $0.35 per share versus the Zacks Consensus Estimate of a loss of $0.40. This compares to loss of $0.55 per share a year ago. These ...

C4 Therapeutics (CCCC) announced its partner Betta Pharmaceuticals has dosed the first patient in the Phase 1 clinical trial of CFT8919, an ...